BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

927 related articles for article (PubMed ID: 15031681)

  • 1. Differential patterns of contrast enhancement in different focal liver lesions after injection of the microbubble US contrast agent SonoVue.
    Quaia E; Degobbis F; Tona G; Mosconi E; Bertolotto M; Pozzi Mucelli R
    Radiol Med; 2004 Mar; 107(3):155-65. PubMed ID: 15031681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue].
    Hohmann J; Skrok J; Puls R; Albrecht T
    Rofo; 2003 Jun; 175(6):835-43. PubMed ID: 12811698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence.
    Quaia E; Calliada F; Bertolotto M; Rossi S; Garioni L; Rosa L; Pozzi-Mucelli R
    Radiology; 2004 Aug; 232(2):420-30. PubMed ID: 15286314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of diagnostic performance of unenhanced vs SonoVue - enhanced ultrasonography in focal liver lesions characterization. The experience of three Italian centers.
    Quaia E; Stacul F; Gaiani S; Ricci P; Passariello R; Curzio D; Pozzi Mucelli R
    Radiol Med; 2004; 108(1-2):71-81. PubMed ID: 15269691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. US characterization of focal hepatic lesions with intermittent high-acoustic-power mode and contrast material.
    Quaia E; Bertolotto M; Calderan L; Mosconi E; Mucelli RP
    Acad Radiol; 2003 Jul; 10(7):739-50. PubMed ID: 12862283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of focal liver lesions with a new ultrasound contrast agent using continuous low acoustic power imaging: comparison with contrast enhanced spiral CT.
    Passamonti M; Vercelli A; Azzaretti A; Rodolico G; Calliada F
    Radiol Med; 2005 Apr; 109(4):358-69. PubMed ID: 15883520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of focal hepatic lesions in cirrhotic patients by Pulse Inversion Harmonic Imaging US contrast specific technique with Levovist.
    Quaia E; Forgács B; Calderan L; Bertolotto M; Pozzi Mucelli R
    Radiol Med; 2002 Oct; 104(4):285-94. PubMed ID: 12569309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Focal hepatic lesions: evaluation with contrast-enhanced gray-scale harmonic US.
    Jang HJ; Lim HK; Lee WJ; Kim SH; Kim MJ; Choi D; Lee SJ; Lim JH
    Korean J Radiol; 2003; 4(2):91-100. PubMed ID: 12845304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of benign hepatic tumors arising in fatty liver with SonoVue and pulse inversion US.
    Bartolotta TV; Midiri M; Galia M; Rollandi GA; Cademartiri F; Lagalla R; Cardinale AE
    Abdom Imaging; 2007; 32(1):84-91. PubMed ID: 16583251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast-enhanced ultrasound with SonoVue: differentiation between benign and malignant focal liver lesions in 317 patients.
    von Herbay A; Westendorff J; Gregor M
    J Clin Ultrasound; 2010 Jan; 38(1):1-9. PubMed ID: 19790253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of focal liver lesions using contrast-enhanced sonography with a low mechanical index mode and a sulfur hexafluoride-filled microbubble contrast agent.
    Xu HX; Liu GJ; Lu MD; Xie XY; Xu ZF; Zheng YL; Liang JY
    J Clin Ultrasound; 2006; 34(6):261-72. PubMed ID: 16788957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-specific vascularization pattern of liver metastasis, hepatocellular carcinoma, hemangioma and focal nodular hyperplasia in the differential diagnosis of 1,349 liver lesions in contrast-enhanced ultrasound (CEUS).
    Strobel D; Seitz K; Blank W; Schuler A; Dietrich CF; von Herbay A; Friedrich-Rust M; Bernatik T
    Ultraschall Med; 2009 Aug; 30(4):376-82. PubMed ID: 19688669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-time contrast-enhanced ultrasonography of resected and immunohistochemically proven hepatic angiomyolipomas.
    Li R; Zhang X; Hua X; Cai P; Zhong H; Guo Y; Ding S; Yan X
    Abdom Imaging; 2010 Dec; 35(6):676-82. PubMed ID: 20020286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-time imaging with the sonographic contrast agent SonoVue: differentiation between benign and malignant hepatic lesions.
    von Herbay A; Vogt C; Willers R; Häussinger D
    J Ultrasound Med; 2004 Dec; 23(12):1557-68. PubMed ID: 15557299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arterioportal shunt: prevalence in small hemangiomas versus that in hepatocellular carcinomas 3 cm or smaller at two-phase helical CT.
    Byun JH; Kim TK; Lee CW; Lee JK; Kim AY; Kim PN; Ha HK; Lee MG
    Radiology; 2004 Aug; 232(2):354-60. PubMed ID: 15215556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging of focal liver lesions: low-mechanical-index real-time ultrasonography with SonoVue.
    Ding H; Wang WP; Huang BJ; Wei RX; He NA; Qi Q; Li CL
    J Ultrasound Med; 2005 Mar; 24(3):285-97. PubMed ID: 15723841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential diagnosis of hepatic tumors: value of contrast-enhanced harmonic sonography using the newly developed contrast agent, Sonazoid.
    Hatanaka K; Kudo M; Minami Y; Ueda T; Tatsumi C; Kitai S; Takahashi S; Inoue T; Hagiwara S; Chung H; Ueshima K; Maekawa K
    Intervirology; 2008; 51 Suppl 1():61-9. PubMed ID: 18544950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of different contrast enhancement patterns after microbubble-based contrast agent injection in liver hemangiomas with atypical appearance on baseline scan.
    Quaia E; Bartolotta TV; Midiri M; Cernic S; Belgrano M; Cova M
    Abdom Imaging; 2006; 31(1):59-64. PubMed ID: 16333704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unclear focal liver lesions in contrast-enhanced ultrasonography--lessons to be learned from the DEGUM multicenter study for the characterization of liver tumors.
    Bernatik T; Seitz K; Blank W; Schuler A; Dietrich CF; Strobel D
    Ultraschall Med; 2010 Dec; 31(6):577-81. PubMed ID: 20740399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of hepatocellular carcinoma using SonoVue, a second generation ultrasound contrast agent: correlation with cellular differentiation.
    Nicolau C; Catalá V; Vilana R; Gilabert R; Bianchi L; Solé M; Pagés M; Brú C
    Eur Radiol; 2004 Jun; 14(6):1092-9. PubMed ID: 15007620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.